Similar Articles
101 Autoimmune pancreatitis and pancreatic cancer: Epidemiological aspects and immunological considerations
102 Natural killer cells in pancreatic cancer stroma
103 Room for improvement in the treatment of pancreatic cancer: Novel opportunities from gene targeted therapy
104 Borderline resectable pancreatic cancer: Certainties and controversies
105 Targeting of elevated cell surface phosphatidylserine with saposin C-dioleoylphosphatidylserine nanodrug as individual or combination therapy for pancreatic cancer
106 Association between oral contraceptive use and pancreatic cancer risk: A systematic review and meta-analysis
107 Burden of venous thromboembolism in patients with pancreatic cancer
108 Stroma-targeting strategies in pancreatic cancer: Past lessons, challenges and prospects
109 Post-pancreatitis diabetes mellitus and excess intra-pancreatic fat deposition as harbingers of pancreatic cancer
110 BRCA mutated pancreatic cancer: A change is coming
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA